Table 2.

Mean ± Standard Error (Likert scale from -5 to +5) sort in descending order to the questions “How much does HC/HT increase or reduce the risk of developing these diseases?” and “How much does HC/HT improve or worsen these symptoms?” for the whole study group and for premenopausal vs. postmenopausal women, separately.

How much does HC/HT increase or reduce the risk of developing these diseases?
	Total group (n = 370)	Premenopausal women (n = 198)	Postmenopausal women (n = 172)	p
Venous thrombosis	1.4 ± 0.1	1.8 ± 0.2	0.8 ± 0.2	<.0001
Breast cysts	0.6 ± 0.1	0.5 ± 0.1	0.7 ± 0.2	.33
Cardiovascular diseases	0.5 ± 0.1	0.9 ± 0.1	0.1 ± 0.2	.0003
Depression	0.0 ± 0.1	0.6 ± 0.1	−0.6 ± 0.2	<.0001
How much does HC/HT improve or worsen these symptoms?
Headache	0.4 ± 0.1	0.3 ± 0.2	0.5 ± 0.2	.37
Mood swings	0.4 ± 0.1	0.5 ± 0.2	0.1 ± 0.2	.15
Weight increase	0.3 ± 0.1	0.0 ± 0.2	0.7 ± 0.2	.02
Increased appetite	0.3 ± 0.1	0.4 ± 0.1	0.3 ± 0.2	.82
Vaginal dryness	0.0 ± 0.1	−0.1 ± 0.1	0.1 ± 0.2	.36
Reduction of libido	−0.1 ± 0.1	−0.1 ± 0.1	−0.1 ± 0.2	.78

Bold characters represent statistically significant results (p < .05).